Mobia Medical, Inc. Common Stock (MOBI) - Total Liabilities
Based on the latest financial reports, Mobia Medical, Inc. Common Stock (MOBI) has total liabilities worth $241.34 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Mobia Medical, Inc. Common Stock - Total Liabilities Trend (2024–2025)
This chart illustrates how Mobia Medical, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Mobia Medical, Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
Mobia Medical, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Mobia Medical, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhangjiagang Zhonghuan Hailu High-End Equipment Co. Ltd.
SHE:301040
|
China | CN¥686.37 Million |
|
Emergent Biosolutions Inc
NYSE:EBS
|
USA | $797.30 Million |
|
Yunnan Jinggu Forestry Co Ltd
SHG:600265
|
China | CN¥126.11 Million |
|
Norske Skog Asa
OL:NSKOG
|
Norway | Nkr8.29 Billion |
|
WONIK Materials Co.Ltd
KQ:104830
|
Korea | ₩124.00 Billion |
|
Johnson Controls - Hitachi Air Conditioning India Limited
NSE:JCHAC
|
India | Rs7.29 Billion |
|
Eurocharm Holdings Co Ltd
TW:5288
|
Taiwan | NT$2.03 Billion |
Liability Composition Analysis (2024–2025)
This chart breaks down Mobia Medical, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Mobia Medical, Inc. Common Stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mobia Medical, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mobia Medical, Inc. Common Stock (2024–2025)
The table below shows the annual total liabilities of Mobia Medical, Inc. Common Stock from 2024 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $198.92 Million | +55.25% |
| 2024-12-31 | $128.13 Million | -- |
About Mobia Medical, Inc. Common Stock
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable devi… Read more